Search - tctmd.com

Displaying 1 - 20 of 156

Sort: Relevancy | Date

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown

May 16, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2025

Caitlin E. Cox

April 30, 2025

News Conference News ACC 2025

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

Michael O'Riordan

April 02, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Daily News

Ataciguat Shows Potential for Curbing Progression of Aortic Stenosis

Yael L. Maxwell

February 27, 2025

News Opinion CV Team Dispatch

February 2025 Dispatch for the CV Team

L.A. McKeown

February 01, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2024

Shelley Wood

December 03, 2024

News Daily News

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Michael O'Riordan

November 11, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Daily News

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

Michael O'Riordan

July 09, 2024

News Conference News NY Valves 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Michael O'Riordan

June 12, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Daily News

Diltiazem and DOAC Interaction Increases Bleeding Risk in AF

L.A. McKeown

April 18, 2024

News Conference News ACC 2024

Need a Statin for Primary Prevention? There’s an App for That

Michael O'Riordan

April 10, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

News Conference News ISC 2024

Speedier Anticoagulation Reversal Tied to Better ICH Outcomes

Todd Neale

February 15, 2024

News Daily News

BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes

Todd Neale

February 02, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Daily News

SAXOPHONE Bolsters Apixaban for Pediatric Heart Disease

Todd Neale

December 05, 2023

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

Advertisement

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

TCTMD’s Top 10 Most Popular Stories for April 2025

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

What’s Going to Be Hot at ACC 2025?

Ataciguat Shows Potential for Curbing Progression of Aortic Stenosis

February 2025 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for November 2024

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

September 2024 Dispatch for the CV Team

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

May 2024 Dispatch for the CV Team

Diltiazem and DOAC Interaction Increases Bleeding Risk in AF

Need a Statin for Primary Prevention? There’s an App for That

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Speedier Anticoagulation Reversal Tied to Better ICH Outcomes

BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

SAXOPHONE Bolsters Apixaban for Pediatric Heart Disease

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content